Simultaneous placement of a bone cement implant after evisceration surgery in patients diagnosed with infectious endophthalmitis

Abstract

Background and objectives

Endophthalmitis is a type of eye inflammation that affects all structures of the eye and is generally of infectious origin. In cases recalcitrant to intravitreal treatment or posterior vitrectomy, evisceration or enucleation are the preferable options. Polymethylmethacrylate (PMMA) bone cement has stood out as an implant in other areas of medicine due to its great stability and healing. In this study, we will evaluate the safety and extrusion rate of the antibiotic-reinforced bone cement implant when it is decided to place it at the same surgical time as an evisceration indicated for infective endophthalmitis.

Materials and methods

Subjects of any age and gender from the Oculoplastic outpatient clinic of the Instituto de Oftalmología Fundación Conde de Valenciana, with a diagnosis of infectious endophthalmitis who required evisceration between the months of May and October 2012, were included.

Results

20 subjects were included, of which 55% (11) were men, and 45% (9) women, with an average age range of 51–80 years. No complications were evidenced in the immediate postoperative period or in the follow-up of 1, 3 and 6 months, and in all cases, the correct position of the implant was confirmed with computed tomography.

Conclusions

In patients diagnosed with infectious endophthalmitis of any cause, evisceration and implantation of bone cement in a single surgical time is a safe and effective option.